UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Cleveland BioLabs is implementing good security practices.
Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development.
This report shows a preliminary security rating for Cleveland BioLabs. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Third-party vendors are an important source of strategic advantage, cost savings and expertise. Yet ...
Ransomware is a type of malicious software, or malware, designed to deny access to a computer ...
Compare Cleveland BioLabs's security performance with other companies